Mansfield Advisors LLP

Mansfield Advisors is a fast growing, leading strategy consulting firm with a 100% focus on the healthcare, social care, education, life sciences, pharma and veterinary markets. We are passionate about our sectors and believe we can make a positive impact on the world by continually striving to improve care delivery.

Founded in 2013 by two former McKinsey consultants and based in the King’s Fund Health Campus off Harley Street in the heart of healthcare London, our consultants include scientists, medical doctors and vets, supported by Senior Advisors who are often former CEOs with direct operational expertise. Whilst we are based in London, our focus is European and our multilingual team international.

Our values are transparency, curiosity, collaboration and commerciality and we believe we have a uniquely open and supportive culture. We invest heavily in our employees with the aim of building a high achieving diverse team who are rewarded for their hard work and who feel they play a part in the direction and focus of the company – this was a founding principle of the firm. We also have a strong track record of taking doctors, vets, dentists and scientist and turning them into commercial strategy consultants.

Our aim is to work for public and private companies and investors, helping them buy, sell and grow businesses by advising on commercial due diligence and corporate strategy, leveraging our 30 years of knowledge, big-data analytics, proprietary databases and clinical and technical sector expertise.
We have been ranked by our clients and competitors one of the UK’s leading healthcare and life sciences management consultants by the Financial Times and Statista in 2022 and a Top 20 Consulting Firm in EMEA 2022 by Firsthand’s Vault, across all sectors and geographies.

Our strategy is to continue to deliver big 3 consulting firm quality work and grow our headcount, revenues and reputation to be one of the UK’s leading healthcare and life sciences management consultants.

Clients

We work with a wide range of investors (private equity, infrastructure, Sovereign Wealth Funds and Hedge Funds) as well as companies, regulators and government.